Multimodality therapy including salvage surgical resection and intraoperative radiotherapy for patients with squamous-cell carcinoma of the anus with residual or recurrent disease after primary chemoradiotherapy

Diseases of the Colon and Rectum

Volumn 57, Issue 4, 2014, Pages 442-448

  Hallemeier, Christopher L ^a   You, Y Nancy ^b   Larson, David W ^a   Dozois, Eric J ^a   Nelson, Heidi ^a   Klein, Kristi A ^a   Miller, Robert C ^a   Haddock, Michael G ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Abdominoperineal resection; Anal cancer; Intraoperative radiotherapy; Multimodality therapy

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ANUS CARCINOMA; ANUS SQUAMOUS CELL CARCINOMA; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONFERENCE PAPER; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INTESTINE OBSTRUCTION; INTRAOPERATIVE RADIOTHERAPY; LENGTH OF STAY; LIVER METASTASIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PROSPECTIVE STUDY; RECTUM ABDOMINOPERINEAL RESECTION; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; SURGICAL MORTALITY; URETER OBSTRUCTION; VERY ELDERLY; WOUND COMPLICATION;

ADULT; AGED; AGED, 80 AND OVER; ANAL CANAL; ANUS NEOPLASMS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84898725306     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0000000000000071     Document Type: Conference Paper

References (24)

1. Gunderson LL, Winter KA, Ajani JA, et al. Long-term update of US GI intergroup RTO G 98-11 phase II trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/ mitomycin vs fluorouracil/cisplatin. J Clin Oncol. 2012;30:4344-4351.
2. James RD, Glynne-Jones R, Meadows HM, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. Lancet Oncol. 2013;14:516-524.
3. Kachnic LA, Winter K, Myerson RJ, et al. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 2013;86:27-33.
4. Renehan AG, Saunders MP, Schofield PF, O'Dwyer ST. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. Br J Surg. 2005;92:605-614.
5. Mullen JT, Rodriguez-Bigas MA, Chang GJ, et al. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal. Ann Surg Oncol. 2007;14:478-483.
6. Schiller DE, Cummings BJ, Rai S, et al. Outcomes of salvage surgery for squamous cell carcinoma of the anal canal. Ann Surg Oncol. 2007;14:2780-2789.
7. Eeson G, Foo M, Harrow S, McGregor G, Hay J. Outcomes of salvage surgery for epidermoid carcinoma of the anus following failed combined modality treatment. Am J Surg. 2011;201:628-633.
8. Allal AS, Laurencet FM, Reymond MA, Kurtz JM, Marti MC. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment. Cancer. 1999;86:405-409.
9. Akbari RP, Paty PB, Guillem JG, et al. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy. Dis Colon Rectum. 2004;47:1136-1144.
10. Rouquie D, Lasser P, Castaing M, et al. [Complete (R0) resection is the only valid prognostic factor in abdominoperineal resection for recurrent cancer of the anal canal (a consecutive series of 95 patients)] (in French). J Chir (Paris). 2008;145:335-340.
11. Stewart D, Yan Y, Kodner IJ, et al. Salvage surgery after failed chemoradiation for anal canal cancer: should the paradigm be changed for high-risk tumors? J Gastrointest Surg. 2007;11:1744-1751.
12. Haddock MG, Miller RC, Nelson H, et al. Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer. Int J Radiat Oncol Biol Phys. 2011;79:143-150.
13. Tepper JE, Gunderson LL, Orlow E, et al. Complications of intraoperative radiation therapy. Int J Radiat Oncol Biol Phys. 1984;10:1831-1839.
14. Tan KK, Pal S, Lee PJ, Rodwell L, Solomon MJ. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca: a single institution's experience over 16 years. Colorectal Dis. 2013;15:1227-1231.
15. Wright JL, Gollub MJ, Weiser MR, et al. Surgery and high-dose-rate intraoperative radiation therapy for recurrent squamous-cell carcinoma of the anal canal. Dis Colon Rectum. 2011;54:1090-1097.
16. Mariani P, Ghanneme A, De la Rochefordière A, Girodet J, Falcou MC, Salmon RJ. Abdominoperineal resection for anal cancer. Dis Colon Rectum. 2008;51:1495-1501.
17. Nilsson PJ, Svensson C, Goldman S, Glimelius B. Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg. 2002;89:1425-1429.
18. Haddock MG, Gunderson LL, Nelson H, et al. Intraoperative irradiation for locally recurrent colorectal cancer in previously irradiated patients. Int J Radiat Oncol Biol Phys. 2001;49:1267-1274.
19. Lefevre JH, Parc Y, Kernéis S, et al. Abdomino-perineal resection for anal cancer: impact of a vertical rectus abdominis myocutaneous flap on survival, recurrence, morbidity, and wound healing. Ann Surg. 2009;250:707-711.
20. Sunesen KG, Buntzen S, Tei T, Lindegaard JC, Nørgaard M, Laurberg S. Perineal healing and survival after anal cancer salvage surgery: 10-year experience with primary perineal reconstruction using the vertical rectus abdominis myocutaneous (VRAM) flap. Ann Surg Oncol. 2009;16:68-77.
21. Mistrangelo M, Pelosi E, Bellò M, et al. Role of positron emission tomography-computed tomography in the management of anal cancer. Int J Radiat Oncol Biol Phys. 2012;84:66-72.
22. Sveistrup J, Loft A, Berthelsen AK, Henriksen BM, Nielsen MB, Engelholm SA. Positron emission tomography/computed tomography in the staging and treatment of anal cancer. Int J Radiat Oncol Biol Phys. 2012;83:134-141.
23. Winton Ed, Heriot AG, Ng M, et al. The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer. Br J Cancer. 2009;100:693-700.
24. Schwarz JK, Siegel BA, Dehdashti F, Myerson RJ, Fleshman JW, Grigsby PW. Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer. Int J Radiat Oncol Biol Phys. 2008;71:180-186.